Is Pfizer Stock A Better Pick Over This Pharmaceuticals Bellwether?

We believe that Pfizer stock (NYSE: PFE) is currently a better pick than its peer, Johnson & Johnson stock (NYSE: JNJ), given its relatively lower valuation of 3.1x trailing revenues, compared to 4.9x for J&J. We think that this valuation gap should narrow, given Pfizer’s If we look at stock…#pfizers #peercomparisons #jjs #johnsonjohnsonoperatingincomecompa #stelara #pfizer #pfe #johnsonjohnson #darzalex #merck

Source: Reuters: Health - December 16, 2022 Category: Consumer Health News Source Type: news